Single-ring Posterior Left Atrial (box) Isolation Results in a Different Mode of Recurrence Compared with Wide Antral Pulmonary Vein Isolation on Long-term Follow-up: Longer Atrial Fibrillation-free Survival Time but Similar Survival Time Free Of...
Overview
Authors
Affiliations
Background: Electric isolation of the pulmonary veins and posterior left atrium with a single ring of radiofrequency lesions (single-ring isolation [SRI]) may result in fewer atrial fibrillation (AF) recurrences than wide antral pulmonary vein isolation (wide antral isolation [WAI]) by abolishing extravenous AF triggers. The effect of mitral isthmus line (MIL) ablation on outcomes after SRI has not previously been assessed.
Methods And Results: We randomly assigned 220 consecutive patients (58 ± 10 years old; 82% men) with highly symptomatic AF (61% paroxysmal, 39% persistent/longstanding persistent) to undergo either SRI or WAI. Half of each cohort was also randomly allocated to have left lateral MIL ablation (2 ×2 factorial study design). Patients were followed clinically and with 7-day Holter studies for arrhythmia recurrences. The primary end points were recurrence of AF and organized atrial tachyarrhythmias. AF-free survival at 2 years was better after SRI (74% [95% CI, 65%-82%]) than WAI (61% [51%-70%]; P=0.031). Organized atrial tachyarrhythmia-free survival was similar after SRI and WAI (67% [57%-75%] ersus 64% [54%-72%], respectively, at 2 years; P=0.988). MIL ablation resulted in better 2-year organized atrial tachyarrhythmia-free survival (71% [62%-79%] versus 60% [50%-69%]; P=0.07), which approached statistical significance. Survival free of any atrial arrhythmia after one procedure was not significantly affected by isolation technique or MIL ablation. Conclusions- SRI resulted in fewer AF recurrences compared with WAI on long-term follow-up but did not reduce the recurrence of all atrial arrhythmias. MIL ablation may reduce organized atrial tachyarrhythmia recurrences. Clinical Trial Registration- http://www.anzctr.org.au; ACTRN12606000467538.
Integrated Management of Persistent Atrial Fibrillation.
Yue X, Zhou L, Zhao C Biomedicines. 2025; 13(1).
PMID: 39857675 PMC: 11760448. DOI: 10.3390/biomedicines13010091.
Conti S, Sabatino F, Randazzo G, Ferrara G, Cascino A, Sgarito G J Cardiovasc Dev Dis. 2024; 11(9).
PMID: 39330352 PMC: 11432285. DOI: 10.3390/jcdd11090294.
Chou A, Jongnarangsin K, Yokokawa M, Ghannam M, Liang J, Oral H J Interv Card Electrophysiol. 2024; 67(5):1219-1228.
PMID: 38411857 DOI: 10.1007/s10840-024-01769-z.
Badertscher P, Mannhart D, Weidlich S, Krisai P, Voellmin G, Osswald S J Interv Card Electrophysiol. 2024; 67(6):1359-1364.
PMID: 38182965 PMC: 11379758. DOI: 10.1007/s10840-023-01728-0.
Conti S, Sabatino F, Fortunato F, Ferrara G, Cascino A, Sgarito G J Clin Med. 2023; 12(16).
PMID: 37629269 PMC: 10455235. DOI: 10.3390/jcm12165228.